bw 373u86 has been researched along with beta-funaltrexamine in 1 studies
| Studies (bw 373u86) | Trials (bw 373u86) | Recent Studies (post-2010) (bw 373u86) | Studies (beta-funaltrexamine) | Trials (beta-funaltrexamine) | Recent Studies (post-2010) (beta-funaltrexamine) |
|---|---|---|---|---|---|
| 80 | 0 | 4 | 542 | 1 | 54 |
| Protein | Taxonomy | bw 373u86 (IC50) | beta-funaltrexamine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.082 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.082 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bofetiado, DM; D'Alecy, LG; Mayfield, KP | 1 |
1 other study(ies) available for bw 373u86 and beta-funaltrexamine
| Article | Year |
|---|---|
Alkaloid delta agonist BW373U86 increases hypoxic tolerance.
Topics: Acute Disease; Animals; Benzamides; Body Temperature; Dose-Response Relationship, Drug; Hypoxia; Male; Mice; Mice, Inbred Strains; Naltrexone; Narcotic Antagonists; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1996 |